Thoracic Oncology 2019
Cart 0

iStock-961295726.jpg
 

Thoracic Oncology 2019 focuses on the future of integrated practice for non-small cell lung cancer with a superb international faculty delivering short presentations with interactive audience participation.

Click here to reserve your place!

 

28-29 November 2019

Millennium Gloucester Hotel, London, united kingdom

Endorsed by:

IASLC-Logos-HZ-tag (2).png

Supported by:

AME logo.jpg
Blank.jpg
Blank Space Holder Image.jpg
 

28 November 2019 (Day 1)

Future of early disease identification

11:00 Overview of lung cancer screening - Harry de Koning, Erasmus MC, Netherlands

11:10 Radiologic diagnosis of lung cancer - Anand Deveraj, Royal Brompton Hospital, London

11:20 Pre-operative biopsy and localisation techniques - Simon Padley, Royal Brompton Hospital, London

11:30 Operative biopsy and localisation techniques - Calvin Ng, Prince of Wales Hospital, Hong Kong

Future of locally ablative treatments (I)

12:00 Overview of sub-solid lesions - TBC

12:10 Surveillance versus resection - Dominique Gossot, Institut du Thorax Curie-Montsouris, Paris

12:20 Local versus anatomic resection - Hiaso Asamura, Keio University School of Medicine, Tokyo

13:00 Lunch

Future of locally ablative treatments (II)

14:00 Novel techniques for lung cancer resection - Joel Dunning, South Tees Hospital, Middlesborough

14:10 Single port surgery - Alan Sihoe, The University of Hong Kong Shenzhen Hospital, Hong Kong

14:20 Robotic surgery - Giulia Veronese, Humanitas Research Hospital, Milan

Future of locally ablative treatments (III)

15:00 Overview of SABR versus surgery trials - Kevin Franks - Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust, Leeds

15:10 SABR for "low risk" NSCLC - Suresh Senan, Amsterdam University Medical Center, Amsterdam

15:20 SABR for "high risk" NSCLC - Hiran (Chrish) Fernando, Inova Fairfax Medical Campus, Virginia Commonwealth University, Virginia

Future of locally ablative treatments (IV)

16:30 MR Linac & proton beam therapy - Corinne Faivre-Finn, Christie Hospital, Manchester

16:40 ENB guided local ablation - Calvin Ng, Prince of Wales Hospital, Hong Kong

16:50 Radiofrequency ablation - Simon Padley, Royal Brompton Hospital, London

18:00 Surgery, Statistics and Science

Inaugural Lecture by Professor Eric Lim, Imperial College London

29 November 2019 (Day 2)

Integrated care of early stage NSCLC

09:00 Surgery and chemotherapy - David Gilligan, Addenbrookes Hospital, Cambridge

09:10 Surgery and radiotherapy - Ceclie Le Pechoux, Institut Gustave Roussy, Paris

09:40 Surgery and adjuvant molecular targeted treatment - Wu Yi Long, Guangdong General Hospital, Guang Zhou

09:40 Surgery and adjuvant immunotherapy - Mary O'Brien, Royal Marsden Hospital, London

09:40 Neo-adjuvant immunotherapy and surgery - Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York

09:50 Primary immnotherapy - Enriqueta Felip, Vall d'Hebron Institute of Oncology, Barcelona

Integrated care of stage III NSCLC

11:00 Surgery and chemotherapy - Eric Lim, Royal Brompton Hospital, London

11:10 Radiotherapy and immunotherapy - Corinne Faivre-Finn, Christie Hospital, Manchester

11:20 Chemotherapy and immunotherapy - Martin Reck, Lung Clinic Grosshansdorf, Grosshansdorf

Integrated care of advanced NSCLC

13:00 Molecular targeted treatment in the era of immuno-oncology - Tony Mok, Chinese University of Hong Kong, Hong Kong

13:10 Immunotherapy - Martin Reck, Lung Clinic Grosshansdorf, Grosshansdorf

13:20 Chemotherapy with immunotherapy - Enriqueta Felip, all d'Hebron Institute of Oncology, Barcelona

Integrated care of “oligometastatic” NSCLC

14:00 Radiotherapy and chemotherapy - Suresh Senan, Amsterdam University Medical Center, Amsterdam

14:10 Radiotherapy and immunotherapy - David Palma, London Health Sciences Centre, Ontario

14:20 Surgery and immunotherapy - Eric Lim, Royal Brompton Hospital, London

Novel approaches to advanced disease

15:30 Population approach to personalised molecular targeted therapy - Sanjay Popat, Royal Marsden Hospital, London

15:40 Adoptive T cell therapy for lung cancer - Alastair Greystoke, Newcastle University, Newcastle upon Tyne

15:50 New immunotherapeutic approaches for lung cancer - Sergio Quezada, University College London, London

16:30 Close of meeting

 
171717.jpg
 

conference Venue

Millennium Gloucester Hotel

4 Harrington Gardens

London SW7 4LH

 

Dates

Thu 28 November 2019 (11:00 am to 5:20 pm)

Fri 29 November 2019 (9:00 am to 4:30 pm)